Campaign India Team
Apr 23, 2008

Sanjay Sipahimalani quits VGC, joins Bates David

Vyas Giannetti Creative’s executive creative director Sanjay Sipahimalani has called it quits. He is joining Bates David Enterprise in a similar role. When contacted by Campaign India, he confirmed his move. Before VGC, Sipahimalani has worked for various agencies including Grey Worldwide, Publicis Ambience, Euro RSCG, Lowe and SSC&B Lintas. He started his career with Ogilvy Benson & Mather as a copywriter. His brand portfolio includes Tata Safari, Philips, Saffola, Kinetic motorcycles, Kotak Mahindra, Nestle’s Maggi and ABN Amro Bank.

Sanjay Sipahimalani quits VGC, joins Bates David
Vyas Giannetti Creative’s executive creative director Sanjay Sipahimalani has called it quits. He is joining Bates David Enterprise in a similar role. When contacted by Campaign India, he confirmed his move. Before VGC, Sipahimalani has worked for various agencies including Grey Worldwide, Publicis Ambience, Euro RSCG, Lowe and SSC&B Lintas. He started his career with Ogilvy Benson & Mather as a copywriter. His brand portfolio includes Tata Safari, Philips, Saffola, Kinetic motorcycles, Kotak Mahindra, Nestle’s Maggi and ABN Amro Bank.
Source:
Campaign India

Related Articles

Just Published

23 hours ago

IPG Mediabrands launches global ecommerce unit ...

In India Interactive Avenues - A Reprise Network Company will lead the ecommerce offering

1 day ago

Twitter ad revenue bolstered by return of events

Advertisers return to Twitter as product launches and live events begin to resurface worldwide.

1 day ago

Amazon triples net income, nears $100 billion in ...

International operations turned a profit of $407 million, while revenue for the company's 'other' category, which is mainly its advertising services, grew 50% year over year.

1 day ago

Facebook ad revenue boosted by commerce uptick

APAC led user growth, as Mark Zuckerberg said Facebook benefits from people and businesses "relying" on its platforms to stay connected and make money during Covid-19.